Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bottles, Rx only, Manufa...

FDA Drug Recall #D-0372-2022 - Class II, December 27, 2021

Recall Summary

Recall Number D-0372-2022
Classification Class II - Moderate risk
Date Initiated December 27, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Padagis US LLC
Location Minneapolis, MN
Product Type Drugs
Quantity 11,868 bottles

Product Description

Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bottles, Rx only, Manufactured by Perrigo, Yeruham, Israel; Distributed by Perrigo, Allegan, MI 49010, NDC 45802-210-02

Reason for Recall

Defective Delivery System

Distribution Pattern

Nationwide USA

Lot / Code Information

Lot, expiry: Lot 150892, exp Oct 2022; Lot 153199, exp Feb 2023; Lot 156041, exp Apr 2023

Other Recalls from Padagis US LLC

Recall # Classification Product Date
D-0677-2026 Class II Nystatin Cream USP, (100,000 USP Nystatin Units... Jun 23, 2026
D-0246-2025 Class II Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per ... Feb 6, 2025
D-0048-2025 Class III Triamcinolone Acetonide Cream USP, 0.025%, 1 LB... Oct 11, 2024
D-0139-2024 Class II Trospium Chloride Extended-Release Capsules, 60... Nov 1, 2023
D-0081-2024 Class II Gynazole-1, (Butoconazole Nitrate) Vaginal Crea... Sep 28, 2023

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping, abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.